Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neuralstem has filed suit against StemCells, stating, among other things, that StemCells intentionally withheld crucial information highly material to the patentability of StemCells's 'new' patent and that this was done with the intent to deceive the US Patent Office in order to get the new patent allowed.
Subscribe to our email newsletter
As a result of these actions, Neuralstem is asking for a declaratory judgment that the patent is unenforceable. The suit was filed in the US District Court of Maryland Southern Division.
Richard Garr, Neuralstem president & CEO, said: “We are confident that their intentional withholding of highly material information and their intent to deceive the Patent Office, will result in this patent being unenforceable.